Center For Scientific Review; Notice of Closed Meetings, 40777-40778 [2017-18118]
Download as PDF
<![CDATA[
40777
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Generic
Clearance to Support the Safe to Sleep®
Campaign at the Eunice Kennedy
Shriver National Institute for Child
Health and Human Development
(NICHD), 0925–0701 Reinstatement
without Change Eunice Kennedy
Shriver National Institute of Child
Health and Human Development
(NICHD), National Institutes of Health
(NIH).
Need and Use of Information
Collection: This is a request to reinstate
without change a generic clearance that
would be used for submissions specific
to the Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD) Safe to Sleep®
(STS) public education campaign.
Submissions for the STS campaign will
be used to assess the understanding and
reach of STS campaign materials and
messages, and to monitor and improve
campaign activities such as training
workshops and overall implementation.
The purpose of this information
collection is to monitor and modify
campaign activities, to plan future
campaign activities, to develop
messages and materials, and to develop
inform current campaign activities; and
(5) inform and/or change practices and
behaviors of program participants.
Examples of the types of information
collections that could be included under
this generic clearance include: Focus
groups and in-depth interviews with
parents/caregivers and/or health
professionals to get feedback on
distribution and outreach activities,
and/or campaign messages; and Surveys
with parents/caregivers and/or health
professionals to: (1) Assess the
usefulness of the new STS campaign
materials, including print and online
materials and a video, (2) track outreach
experiences of program participants, (3)
assess training participants’ changes in
knowledge related to safe infant sleep
behavior and implementation of
outreach methods taught, and (4) assess
program participants’ resource needs.
The sub-studies for this generic
clearance will be small scale, designed
to obtain results frequently and quickly
to guide campaign development and
implementation, inform campaign
direction, and be used internally for
campaign management purposes.
NICHD’s current scope and capacity for
STS generic sub-studies is non-existent
and this request would fill this gap.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
12,920.
distribution and outreach strategies that
are effective at communicating their
message to bring about the intended
response, awareness, and/or behavioral
change for the target audiences. This
generic clearance will enable the NICHD
to: (1) More efficiently assess the
implementation of campaign activities;
(2) better understand the target
audiences’ knowledge, attitudes, and
beliefs toward STS messages and
materials; (3) better understand how the
campaign activities have influenced the
target audiences’ behaviors and
practices; and (4) monitor and improve
activities such as trainings, materials,
and messages. Having a way to gather
feedback on the STS campaign activities
is critical to assessing the reach and
effect of campaign efforts. Data collected
for the campaign can inform where
future STS campaign resources can
produce the most meaningful results.
Data collected for the STS campaign
generic clearance will be used by a
number of audiences, including STS
campaign staff, NICHD leadership, STS
campaign collaborators, Federal SUID/
SIDS Workgroup members, SUID/SIDS
stakeholders, clinical and maternal and
child health professionals. These
audiences may use the information
collections to: (1) Develop new
campaign messages, materials, and/or
training curricula; (2) monitor and
improve campaign activities; (3) make
decisions about campaign activities; (4)
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden
per response
(in hours)
Focus Groups .......................................................
Interviews ..............................................................
Pre/Post Tests ......................................................
Pre/Post Tests ......................................................
Surveys .................................................................
Tracking/Feedback Form ......................................
General Public ..............
General Public ..............
General Public ..............
Health Professionals ....
Health Professionals ....
Health Educators ..........
45
45
3,500
20,000
2,000
40
1
1
2
2
1
2
1
1
15/60
15/60
30/60
1
45
45
1,750
10,000
1,000
80
Total ...............................................................
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Type of
respondents
.......................................
25,630
49,170
........................
12,920
Dated: August 23, 2017.
Jennifer Guimond,
Project Clearance Liaison, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, National Institutes of
Health.
[FR Doc. 2017–18196 Filed 8–25–17; 8:45 am]
18:45 Aug 25, 2017
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
BILLING CODE 4140–01–P
VerDate Sep<11>2014
Number of
respondents
Number
of responses
per
respondent
Form name
Jkt 241001
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Total annual
burden hours
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:
Development of Appropriate Pediatric
Formulations and Pediatric Drug Delivery
Systems.
E:\FR\FM\28AUN1.SGM
28AUN1
asabaliauskas on DSKBBXCHB2PROD with NOTICES
40778
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
Date: September 21–22, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Paek-Gyu Lee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892, (301) 613–
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Cancer-Related Behavioral Research through
Integrating Existing Data.
Date: September 22, 2017.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Suzanne Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 435–
1712, ryansj@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Risk and Disease Prevention
Study Section.
Date: September 25–26, 2017.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Stacey FitzSimmons,
Ph.D., MPH., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3114, MSC 7808, Bethesda, MD 20892,
(301) 451–9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Health Services Organization and Delivery
Study Section.
Date: September 25–26, 2017.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand Chicago
Riverfront, 71 East Wacker Drive, Chicago, IL
60601.
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 806–
0009, brontetinkewjm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
089: Imaging and Biomarkers for Early
Detection of Aggressive Cancer.
Date: September 25, 2017.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
VerDate Sep<11>2014
18:45 Aug 25, 2017
Jkt 241001
Contact Person: Xiang-Ning Li, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112,
MSC 7854, Bethesda, MD 20892, 301–435–
1744, lixiang@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: August 21, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18118 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery (NICHD)
National Institutes of Health,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public to take this opportunity
to comment on the ‘‘Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery ’’
for approval under the Paperwork
Reduction Act (PRA). This collection
was developed as part of a Federal
Government-wide effort to streamline
the process for seeking feedback from
the public on service delivery. This
notice announces our intent to submit
this collection to OMB for approval and
solicits comments on specific aspects
for the proposed information collection.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Jennifer Guimond, Project
Clearance Liaison, Office of Science
Policy, Reporting, and Program
Analysis, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, National
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Institutes of Health, 31 Center Drive,
Room 2A18, Bethesda, Maryland 20892
or call non-toll-free number (301) 496–
1877 or Email your request, including
your address to: Jennifer.guimond@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery (NICHD), 0925–0643,
Expiration Date 10/31/2014,
EXTENSION, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development (NICHD), National
Institutes of Health (NIH).
Need and Use of Information
Collection: There are no changes being
requested for this submission. The
proposed information collection activity
provides a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the Administration’s
commitment to improving service
delivery. By qualitative feedback we
mean information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide information
about the NICHD’s customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 82, Number 165 (Monday, August 28, 2017)]
[Notices]
[Pages 40777-40778]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR: Development of Appropriate Pediatric Formulations and
Pediatric Drug Delivery Systems.
[[Page 40778]]
Date: September 21-22, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paek-Gyu Lee, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4201, MSC 7812, Bethesda, MD 20892, (301) 613-
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Cancer-Related Behavioral Research through
Integrating Existing Data.
Date: September 22, 2017.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Suzanne Ryan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 435-
1712, ryansj@csr.nih.gov.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Psychosocial Risk and Disease Prevention
Study Section.
Date: September 25-26, 2017.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Stacey FitzSimmons, Ph.D., MPH., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD
20892, (301) 451-9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Health Services Organization and Delivery
Study Section.
Date: September 25-26, 2017.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Wyndham Grand Chicago Riverfront, 71 East Wacker Drive,
Chicago, IL 60601.
Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD
20892, (301) 806-0009, brontetinkewjm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-16-089: Imaging and Biomarkers for Early Detection of
Aggressive Cancer.
Date: September 25, 2017.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Xiang-Ning Li, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112, MSC 7854, Bethesda, MD
20892, 301-435-1744, lixiang@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS).
Dated: August 21, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-18118 Filed 8-25-17; 8:45 am]
BILLING CODE 4140-01-P
